Gao Jie, Wu Lingling, Wang Yong, Cui Shaoyuan, Duan Shuwei, Dong Zheyi, Feng Zhe, Chen Xiangmei
Department of Nephrology, The Second Hospital of Jilin University, Changchun, China.
Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, Beijing Key Laboratory of Kidney Disease, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing, China.
Cell Physiol Biochem. 2017;42(5):2118-2129. doi: 10.1159/000479914. Epub 2017 Aug 15.
BACKGROUND/AIMS: IFN-γ-inducible protein 10 (IP-10, CXCL10) has been widely demonstrated to be involved in chemotaxis, cell growth regulation and angiogenesis inhibition. It has been reported that CXCL10 expression is significantly increased in patients with MesPGN (Mesangial proliferative glomerulonephritis). However, the underlying mechanism of CXCL10 in MesPGN reminds unclear.
Wildtype (Cxcl10+/+) mice and Cxcl10-deficient (Cxcl10-/-) mice were used to generate a murine model of MesPGN. The histological changes in glomeruli were examined by PAS staining (Periodic Acid-Schiff staining), and cell proliferation was detected by PCNA immunohistochemistry staining. The expression of cell cycle regulatory proteins was analyzed by Western blotting and the effects of CXCL10 on primary mouse renal mesangial cells (MRMC) proliferation were detected using the EDU assay. Furthermore, the specific mechanisms by which CXCL10 affected mesangial cells were investigated in vitro using a specific inhibitor.
Typical pathological phenotypes were observed in both mouse types, while the Cxcl10-/- mice had lighter accumulation of extracellular matrix, less cell proliferation and diminished up-regulation of cell cycle regulatory proteins compared to Cxcl10+/+ mice at day 7. Furthermore, we observed that CXCL10 inhibition resulted in less activation of ERK phosphorylation, and ERK pathway inhibition by a specific inhibitor, U0126, prevented CXCL10 induced MRMC proliferation and the activation of phosphorylated ERK.
CXCL10 may aggravate mesangial proliferation in MesPGN by activating the ERK signaling pathway. These results provide a novel insight into the mechanism and potential therapy target of MesPGN.
背景/目的:γ-干扰素诱导蛋白10(IP-10,CXCL10)已被广泛证明参与趋化作用、细胞生长调节和血管生成抑制。据报道,系膜增生性肾小球肾炎(MesPGN)患者的CXCL10表达显著增加。然而,CXCL10在MesPGN中的潜在机制仍不清楚。
使用野生型(Cxcl10+/+)小鼠和Cxcl10缺陷型(Cxcl10-/-)小鼠建立MesPGN小鼠模型。通过PAS染色(过碘酸-希夫染色)检查肾小球的组织学变化,并用PCNA免疫组化染色检测细胞增殖。通过蛋白质印迹分析细胞周期调节蛋白的表达,并使用EDU检测法检测CXCL10对原代小鼠肾系膜细胞(MRMC)增殖的影响。此外,在体外使用特异性抑制剂研究CXCL10影响系膜细胞的具体机制。
两种小鼠均观察到典型的病理表型,但在第7天,与Cxcl10+/+小鼠相比,Cxcl10-/-小鼠的细胞外基质积累较轻,细胞增殖较少,细胞周期调节蛋白的上调减少。此外,我们观察到CXCL10抑制导致ERK磷酸化的激活减少,并且特异性抑制剂U0126抑制ERK途径可阻止CXCL10诱导的MRMC增殖和磷酸化ERK的激活。
CXCL10可能通过激活ERK信号通路加重MesPGN中的系膜增殖。这些结果为MesPGN的机制和潜在治疗靶点提供了新的见解。